NeuroOne Medical Technologies Corp (NMTC): Next-Year EPS Estimate 34.23%
As of 2026-05-13, NeuroOne Medical Technologies Corp (NMTC) has a next-year EPS growth estimate of 34.23%.
On 2026-05-13, analyst consensus for NMTC's next-year EPS growth shifted from 33.48% to 34.23% — a positive change of 0.75 percentage points. Current-year growth is projected at -37.04%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 34.23%
- EPS growth this year
- -37.04%
- EPS next quarter (est)
- -$0.19
- Last price
- $4.53
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-13 | 34.23% | -37.04% | -$0.19 | $4.53 |
| 2026-05-12 | 33.48% | -38.27% | -$0.18 | $4.39 |
| 2026-05-11 | 33.48% | -38.27% | -$0.23 | $4.33 |
| 2026-05-10 | 33.48% | -38.27% | -$0.23 | $4.76 |
| 2026-05-07 | 33.48% | -38.27% | -$0.23 | $4.54 |
| 2026-05-06 | 33.48% | -38.27% | -$0.23 | $4.30 |
| 2026-05-05 | 33.48% | -38.27% | -$0.23 | $4.43 |
| 2026-05-04 | 33.48% | -38.27% | -$0.23 | $4.49 |
| 2026-05-03 | 33.48% | -38.27% | -$0.23 | $4.35 |
| 2026-04-30 | 33.48% | -38.27% | -$0.23 | $4.70 |
| 2026-04-29 | 33.48% | -38.27% | -$0.23 | $4.70 |
| 2026-04-28 | 32.43% | -37.04% | -$0.22 | $4.75 |
| 2026-04-27 | 32.43% | -37.04% | -$0.22 | $4.61 |
| 2026-04-26 | 32.43% | -37.04% | -$0.22 | $4.76 |
| 2026-04-24 | 32.43% | -37.04% | -$0.22 | $4.76 |
| 2026-04-23 | 32.43% | -37.04% | -$0.22 | $4.75 |
| 2026-04-22 | 32.43% | -37.04% | -$0.22 | $5.11 |
| 2026-04-21 | 32.43% | -37.04% | -$0.22 | $5.05 |
| 2026-04-20 | 32.43% | -37.04% | -$0.22 | $4.98 |
| 2026-04-19 | 32.43% | -37.04% | -$0.22 | $4.84 |
| 2026-04-16 | 32.43% | -37.04% | -$0.22 | $4.57 |
| 2026-04-15 | 32.43% | -37.04% | -$0.04 | $0.74 |
| 2026-04-14 | 32.43% | -37.04% | -$0.04 | $0.73 |
| 2026-04-13 | 32.43% | -37.04% | -$0.04 | $0.75 |
| 2026-04-12 | 32.43% | -37.04% | -$0.04 | $0.73 |
| 2026-04-10 | 32.43% | -37.04% | -$0.04 | $0.74 |
| 2026-04-09 | 32.43% | -37.04% | -$0.04 | $0.74 |
| 2026-04-08 | 32.43% | N/A | -$0.04 | $0.72 |
| 2026-04-07 | 32.43% | N/A | -$0.04 | $0.83 |
| 2026-04-06 | 32.43% | N/A | -$0.04 | $0.83 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is NeuroOne Medical Technologies Corp's next-year EPS growth estimate?▾
As of 2026-05-13, NeuroOne Medical Technologies Corp (NMTC) has a next-year EPS growth estimate of 34.23%, based on analyst consensus.
When was the latest EPS estimate revision for NMTC?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 33.48% to 34.23%.
What sector and industry does NeuroOne Medical Technologies Corp belong to?▾
NeuroOne Medical Technologies Corp operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NMTC appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. NeuroOne Medical Technologies Corp (NMTC) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports